{
  "compound": "UNKNOWN",
  "condition": "AMYOTROPHIC_LATERAL_SCLEROSIS",
  "effect_size": "none",
  "study_type": "observational",
  "source": "NORML:AMYOTROPHIC_LATERAL_SCLEROSIS_OBSERVATIONAL_003",
  "participants": null,
  "year": null,
  "notes": "The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset",
  "confidence": "medium",
  "abstract": ""
}